Artra Group Corporation (TYO:6029)
Japan · Delayed Price · Currency is JPY 199.00
+1.00 (0.51%)
Jul 24, 2026, 3:30 PM JST
Artra Group Financials Overview
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 3,918 | 3,927 | 4,234 | 4,497 | 4,671 | 3,158 |
Revenue Growth | -6.04% | -7.25% | -5.85% | -3.72% | 47.91% | 30.17% |
Gross Profit Gross Profit Growth | 1,362 | 1,347 | 1,335 | 1,463 | 1,572 | 876 |
Operating Income Operating Income Growth | 179 | 141 | 6 | 51 | 3 | -223 |
Net Income Net Income Growth | 164 | 258 | -36 | 53 | 2 | -351 |
Earnings Per Share EPS Growth | 15.97 | 25.13 | -3.52 | 5.34 | 0.20 | -36.74 |
EPS Growth | - | - | - | 2506.95% | - | - |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Unallocated Adjustment Amount Unallocated Adjustment Amount Growth | -15.44 | -9.25 | -79.54 | -7.2 | - |
Toy Sales Business Toy Sales Business Growth | 1,570 | 1,786 | 1,755 | 1,913 | 325.45 |
Acupuncture and Bonesetting Clinic Support Project Acupuncture and Bonesetting Clinic Support Project Growth | 2,373 | 2,458 | 2,822 | 2,766 | 2,833 |
Total Total Growth | 3,927 | 4,234 | 4,498 | 4,671 | 3,158 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,269 | 1,128 | 1,049 | 1,140 | 1,234 | 1,835 |
Total Debt Total Debt Growth | 791 | 1,049 | 1,278 | 1,535 | 1,905 | 2,434 |
Net Cash (Debt) Net Cash Growth | 478 | 79 | -229 | -395 | -671 | -599 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | 46.56 | 7.69 | -22.40 | -39.76 | -68.66 | -62.71 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | - | 275 | 200 | 217 | -132 | -208 |
Capital Expenditures CapEx Growth | - | -41 | -41 | -75 | -105 | -33 |
Free Cash Flow Free Cash Flow Growth | - | 234 | 159 | 142 | -237 | -241 |
Free Cash Flow Growth | - | 47.17% | 11.97% | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 34.76% | 34.30% | 31.53% | 32.53% | 33.65% | 27.74% |
Operating Margin | 4.57% | 3.59% | 0.14% | 1.13% | 0.06% | -7.06% |
Pretax Margin | 3.78% | 6.14% | -0.50% | 1.60% | 0.56% | -10.51% |
Profit Margin | 4.19% | 6.57% | -0.85% | 1.18% | 0.04% | -11.12% |
FCF Margin | - | 5.96% | 3.75% | 3.16% | -5.07% | -7.63% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 12.46 | 6.77 | - | 36.38 | 915.06 | - |
Forward PE | - | 11.19 | 11.19 | 11.19 | 11.19 | 11.19 |
P/FCF Ratio | - | 7.46 | 8.72 | 13.58 | - | - |
PS Ratio | 0.52 | 0.44 | 0.33 | 0.43 | 0.39 | 0.90 |